Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release (Revised)▲ PositiveExpansion31 Jul 2026

Aether Industries Limited

Press Release (Revised)

Aether Industries Limited, a specialty chemical manufacturer, has collaborated with Dow Chemical International Private Limited to launch a research program to develop new manufacturing technologies for silicones.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion31 Jul 2026

Aether Industries Ltd

Revised Press Release.

Aether Industries Ltd has collaborated with Dow Chemical International Pvt. Ltd. to develop new manufacturing technologies for silicones. The program will be executed at Aether's R&D and pilot facilities in Surat, Gujarat. This collaboration represents a milestone in advancing domestic innovation and has the potential for long-term commercialization and industrial-scale manufacture of technologies developed through the program.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Strides Pharma Science Ltd

Earnings Presentation for the quarter ended June 30, 2026

Strides Pharma Science Ltd has announced its Q1FY27 earnings, with revenue growth of 13% YoY, and EBITDA growth of 5.4% YoY, despite a ₹131m impact on freight and operating costs from geopolitical disruptions. The company has also unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, and improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Strides Pharma Science Ltd

Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12,654m, Grew 13% YoY; Ex-US Markets Grew 17% YoY

Strides Pharma Science Ltd reported Q1FY27 results with revenue at ₹12,654m, a 13% YoY growth, driven by 17% YoY growth in Ex-US Markets. EBITDA grew 5.4% YoY to ₹2,298m, despite a ₹131m impact on operating costs from geopolitical disruptions. The company unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, its captive GCC, while retaining meaningful participation in its future growth.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults31 Jul 2026

Strides Pharma Science Limited

General Updates

Strides Pharma Science Limited has announced its Q1 FY 2027 earnings, with revenue growing 13% YoY to ₹12,654m, and EBITDA growing 5.4% YoY to ₹2,298m. The company has also divested its majority stake in Pivot Path, a captive GCC, and unlocked ₹1,000m of value. The company has improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Shadowfax Technologies Limited

Press Release

Shadowfax Technologies Limited has announced its Q1 FY27 financial results, with revenue growing 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanding to 4.9%, and PAT reaching an all-time high of ₹65 Cr.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Strides Pharma Science Limited

Press Release

Strides Pharma Science Limited has announced its consolidated financial results for the quarter (Q1FY27) ended 30 June, 2026, with revenue at ₹12,654m, growing 13% YoY, and EBITDA at ₹2,298m, growing 5.4% YoY.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026

Strides Pharma Science Limited

Outcome of Board Meeting

Strides Pharma Science Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, to the National Stock Exchange of India and the Bombay Stock Exchange. The results were approved by the Board of Directors at their meeting held on July 31, 2026. The financial results are available on the company's website at www.strides.com.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026

Hybrid Financial Services Limited

Outcome of Board Meeting

Hybrid Financial Services Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a total income of Rs. 151.43 crores and a profit before tax of Rs. 58.22 crores. The company's principal business is stock broking and allied activities.

Read more →📎 1 attachment
NSEPress Release▲ PositiveOrder Win31 Jul 2026

Aether Industries Limited

Press Release

Aether Industries Limited, a specialty chemical manufacturer, has collaborated with Dow Chemical International Private Limited on a research program to develop new manufacturing technologies for silicones in India.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveExpansion31 Jul 2026

Alicon Castalloy Limited

General Updates

Alicon Castalloy Limited has informed the Exchange about setting-up of a new manufacturing facilities/plant for GDC, LPDC, and Machining with a capital outlay of Rs.1,255 million.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

Aether Industries Limited

Investor Presentation

Aether Industries Limited has informed the Exchange about Investor Presentation, with Frequently Asked Questions (FAQs) on the presentation shared, including quarterly performance, site nomenclature, operations and supply chain, and capital expenditure.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Aether Industries Ltd

In accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we further share the FAQs to the investor presentation, as annexed.

Aether Industries Ltd reported strong quarterly sales growth of 27% YoY and 7% QoQ, driven by 75% YoY growth in Contract and Exclusive Manufacturing (CEM) and 20% YoY growth in Contract Research and Manufacturing Services (CRAMS). The company also provided an update on its manufacturing sites, with new names and a focus on diversification across sectors.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

Aether Industries Limited

Investor Presentation

Aether Industries Limited has announced its Q1 FY27 financial results, showing a 27% YoY growth in operating revenue to ₹3,051 M, with a 31% YoY growth in EBITDA to ₹814 M and a 33% YoY growth in PAT to ₹540 M. The company has also provided an update on its R&D expansion plans, including the installation of 18 fume hoods and the construction of a new R&D building.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Aether Industries Ltd

In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the investor presentation is annexed herewith.

Aether Industries Ltd has announced its Q1 FY27 financial results, with a 27% YoY growth in operating revenue to ₹3,051 M, driven by growing CEM contracts and price-led LSM demand. The company has also reported a 31% YoY growth in EBITDA to ₹814 M, and a 33% YoY growth in profit after tax to ₹540 M.

Read more →📎 1 attachment
← PreviousPage 799 of 995Next →